全文获取类型
收费全文 | 90730篇 |
免费 | 9992篇 |
国内免费 | 6662篇 |
专业分类
耳鼻咽喉 | 732篇 |
儿科学 | 1238篇 |
妇产科学 | 1039篇 |
基础医学 | 10008篇 |
口腔科学 | 1795篇 |
临床医学 | 11894篇 |
内科学 | 12658篇 |
皮肤病学 | 791篇 |
神经病学 | 4238篇 |
特种医学 | 3241篇 |
外国民族医学 | 49篇 |
外科学 | 8910篇 |
综合类 | 17235篇 |
现状与发展 | 29篇 |
一般理论 | 17篇 |
预防医学 | 6793篇 |
眼科学 | 2601篇 |
药学 | 9838篇 |
124篇 | |
中国医学 | 6223篇 |
肿瘤学 | 7931篇 |
出版年
2024年 | 327篇 |
2023年 | 1570篇 |
2022年 | 3552篇 |
2021年 | 5273篇 |
2020年 | 3950篇 |
2019年 | 3330篇 |
2018年 | 3376篇 |
2017年 | 3244篇 |
2016年 | 2975篇 |
2015年 | 4566篇 |
2014年 | 5434篇 |
2013年 | 5107篇 |
2012年 | 7303篇 |
2011年 | 7825篇 |
2010年 | 5256篇 |
2009年 | 4478篇 |
2008年 | 5143篇 |
2007年 | 4825篇 |
2006年 | 4741篇 |
2005年 | 4144篇 |
2004年 | 2987篇 |
2003年 | 2716篇 |
2002年 | 2287篇 |
2001年 | 1953篇 |
2000年 | 1799篇 |
1999年 | 1779篇 |
1998年 | 1088篇 |
1997年 | 1003篇 |
1996年 | 804篇 |
1995年 | 749篇 |
1994年 | 661篇 |
1993年 | 392篇 |
1992年 | 487篇 |
1991年 | 403篇 |
1990年 | 322篇 |
1989年 | 328篇 |
1988年 | 283篇 |
1987年 | 241篇 |
1986年 | 148篇 |
1985年 | 141篇 |
1984年 | 79篇 |
1983年 | 60篇 |
1982年 | 46篇 |
1981年 | 40篇 |
1980年 | 26篇 |
1979年 | 41篇 |
1978年 | 20篇 |
1975年 | 12篇 |
1974年 | 11篇 |
1970年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) are a new type of drug for the treatment of diabetes, and they have been proven to have a good hypoglycemic effect. Several lines of clinical evidence have shown that SGLT2 inhibitors can significantly reduce the risks of atherosclerosis, hospitalization for heart failure, cardiovascular death, and all-cause mortality and delay the progression of chronic kidney disease. Because of the protective effects of SGLT2 inhibitors on the heart and kidney, they are being studied for the treatment of heart failure and chronic kidney disease in patients without diabetes. Therefore, it is necessary for cardiologists, patients with diabetes, and nephrologists to fully understand this type of drug. In this review, we summarize the following three aspects of SGLT2 inhibitors: the recent clinical evidence of their cardiovascular benefits, their mechanisms of action, and their safety. 相似文献
52.
53.
Chen Rong Zhang Yuan Huang Lei Cheng Bi-heng Xia Zhong-yuan Meng Qing-tao 《Journal canadien d'anesthésie》2020,67(6):655-663
Canadian Journal of Anesthesia/Journal canadien d'anesthésie - To assess the management and safety of epidural or general anesthesia for Cesarean delivery in parturients with coronavirus... 相似文献
54.
55.
56.
随着对肿瘤热疗和肿瘤免疫微环境(TIME)的深入研究,近年来热疗对TIME的作用越来越受到学者们的重视。本文就目前国内外研究进展,对热疗与TIME中几类主要免疫细胞和免疫相关细胞因子的影响及作用机制作一综述。全面而透彻的了解热疗对TIME的调控作用,有助于为肿瘤治疗提供新的思路和方法。 相似文献
57.
目的探讨T3、T4期结直肠癌患者淋巴结转移危险因素,为临床诊疗提供参考。方法回顾性分析2008年1月至2017年12月在空军军医大学西京消化病医院行结直肠癌根治术的1112例T3、T4期结直肠癌患者的临床病理资料,分析淋巴结转移状态与临床病理因素及肿瘤标志物的相关性,应用logistic多因素回归法分析淋巴结转移的相关危险因素。结果单因素分析结果显示,性别、年龄、肿瘤部位分层的结直肠癌患者间淋巴结转移率差异均无统计学意义(均P>0.05),淋巴结转移率在不同肿瘤长径[<5 cm和≥5 cm分别为37.75%(211/559)、52.26%(289/553),χ^2=23.666,P<0.01]、大体类型[浸润、溃疡、蕈伞、隆起分别为37.04%(20/54)、47.52%(432/909)、34.33%(23/67)、69.51%(57/82),χ^2=13.787,P=0.003]、分化程度[高、中、低分化分别为34.11%(102/299)、49.00%(317/647)、48.80%(81/166),χ^2=19.771,P<0.01]、错配修复缺陷(dMMR)[是和否分别为26.34%(64/243)、50.17%(436/869),χ^2=43.996,P<0.01]、神经侵犯[是和否分别为48.17%(421/874)、33.20%(79/238),χ^2=16.954,P<0.01]、脉管侵犯[是和否分别为79.16%(338/427)、23.65%(162/685),χ^2=327.493,P<0.01]以及术前癌胚抗原(CEA)[阳性(≥5 mg/ml)和阴性(<5 mg/ml)分别为52.87%(249/471)、39.16%(251/641),χ^2=20.162,P<0.01]和CA199[阳性(≥35 U/ml)和阴性(<35 U/ml)分别为59.33%(124/209)、41.64%(376/903),χ^2=21.465,P<0.01]分层患者间差异均有统计学意义。logistic多因素回归分析显示,脉管侵犯和术前CA199阳性是T3、T4期结直肠癌患者淋巴结转移独立危险因素(OR=13.006,95%CI 9.329~17.276,P<0.01;OR=2.194,95%CI 1.513~3.181,P<0.01),dMMR阳性是淋巴结转移的保护性因素(OR=0.279,95%CI 0.190~0.411,P<0.01)。结论脉管侵犯是T3、T4期结直肠癌患者淋巴结转移的主要危险因素。术前肿瘤标志物CA199的检测可以作为预测T3、T4期结直肠癌患者淋巴结转移状态的指标,一定程度上可为诊疗方案的制订提供参考。 相似文献
58.
59.
Yu Fan Xiaoling Liao Yuesong Pan Kehui Dong Yilong Wang Yongjun Wang 《Journal of stroke and cerebrovascular diseases》2019,28(1):220-226
Background
The intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) therapy is safe and efficient during the treatment of acute ischemic stroke. Nonetheless, the different outcomes among various stroke subgroups have limited data with regard to the safety and efficacy of cryptogenic stroke (CS). The present study compared the safety and efficacy when IVT with rt-PA was used for the treatment of CS and the other stroke subtypes.Methods
This study classified the IVT with rt-PA patients within 4.5 hours after stroke onset, based on the trial of ORG 10172 in acute stroke treatment criteria in terms of diagnostic evaluation. The data were obtained from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China database, a large multicenter prospective registry. A multivariable logistic regression model was employed to compare the differences between the subtypes in symptomatic intracerebral hemorrhage (sICH) within 7 days and studied the mortality and the outcome during 90 days.Results
In total, 1118 patients were recruited; of these, 131 (11.7%) suffered from CS and 987 (88.3%) with the other etiology. In the CS group, patients were younger than those in the other etiology groups (P < .001). Moreover, it had a lower prevalence of previous stroke (P?=?.0117), receiving antiplatelet drug in 24 hours prior to thrombolysis (P?=?.0017), and functional independence (mRS > 1 before stroke, P?=?.003). The CS group had lower blood pressure (systolic blood pressure P?=?.0001; diastolic blood pressure; P?=?.0212) before thrombolysis, atrial fibrillation (P < .001), and diabetes mellitus (P?=?.0005). Transient ischemic attack, hypertension, hyperlipidemia, blood glucose, receiving anticoagulants in 24 hours prior to thrombolysis, and standard dosage of rt-PA were equally distributed in both groups. After the adjustment of confounders between the CS and the other subgroups, no obvious differences were observed in sICH rate and mortality (P > .05) The CS patients exhibited excellent recovery (mRS, 0-1; 63.78%) and functional independence (mRS, 0-2; 74.8%) than the large artery atherosclerosis patients.Conclusions
IVT with rt-PA is a safe and effective method for the treatment of CS patients. 相似文献60.
范玲 《中华产科急救电子杂志》2020,9(3):133-135
远程胎儿监护是应用互连网及计算机技术,孕妇在家中或远程监护终端将胎心监护图形传输到中央监护站,医生即可通过电脑或手机APP远程判读。对高危孕妇实行远程监护,便于及时发现胎儿宫内缺氧情况和及时处理,改善围产儿结局。 相似文献